Hospital
Central Montana Medical Facilities, INC
Central Montana Medical Facilities, INC was paid $352K by Medicaid between Jan 2018 and Dec 2024, across 98 billing codes. Its largest line is 99283, emergency room visit (moderate) — 39% of everything it billed.
33Billing provider infoCENTRAL MONTANA MEDICAL FACILITIES, INC
LEWISTOWN, MT 59457
LEWISTOWN, MT 59457
33aNPI1790798387assigned 08/14/2006
33bProvider typeCritical Access Hospital
28Total paid$352K
24GClaims104,985
24DCodes billed98
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Critical Access Hospital providers in Montana
Rank by total paid#12 of 25
Median peer was paid$185K
This provider vs. median1.9×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 16,582 | $33K | |
| 2019 | 15,150 | $40K | |
| 2020 | 12,697 | $42K | |
| 2021 | 14,691 | $46K | |
| 2022 | 17,071 | $62K | |
| 2023 | 16,973 | $76K | |
| 2024incomplete | 11,821 | $52K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 39% | 6,361 | 5,161 | $138K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 14% | 3,551 | 2,582 | $50K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 11% | 2,988 | 2,585 | $40K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 5.3% | 595 | 403 | $19K |
| 71046 | Radiologic examination, chest; 2 views | 3.0% | 1,819 | 1,361 | $11K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 2.6% | 456 | 413 | $9K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 2.1% | 299 | 267 | $7K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 1.9% | 1,642 | 1,329 | $7K |
| 80053 | Comprehensive metabolic panel | 1.4% | 8,123 | 6,502 | $5K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.4% | 2,365 | 1,853 | $5K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.3% | 8,854 | 7,004 | $4K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.2% | 1,525 | 925 | $4K |
86 more codes
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 481 | $3K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 947 | $3K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 2,007 | $3K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 6,919 | $3K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 227 | $3K |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | <1% | 101 | $2K |
| G0378 | Hospital observation service, per hour | <1% | 117 | $2K |
| 81001 | <1% | 3,335 | $2K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 13,736 | $2K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,804 | $2K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 1,368 | $2K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 1,249 | $2K |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 1,107 | $2K |
| 71045 | Radiologic examination, chest; single view | <1% | 427 | $1K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 1,709 | $1K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 352 | $1K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 248 | $997.49 |
| 83605 | <1% | 928 | $972.36 | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 286 | $914.48 |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 839 | $879.55 |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 119 | $819.02 |
| 83690 | <1% | 1,179 | $807.16 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 2,702 | $804.08 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,576 | $801.03 |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 116 | $728.29 |
| 97161 | <1% | 289 | $725.42 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 308 | $692.27 |
| 73610 | <1% | 50 | $680.06 | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,865 | $663.30 |
| 87486 | <1% | 275 | $661.43 | |
| 87581 | <1% | 275 | $661.43 | |
| 84484 | <1% | 1,328 | $604.47 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 519 | $581.30 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,801 | $524.83 |
| 87430 | <1% | 219 | $521.73 | |
| 86140 | <1% | 274 | $486.62 | |
| J2704 | Injection, propofol, 10 mg | <1% | 567 | $455.20 |
| 73630 | <1% | 107 | $414.51 | |
| 80306 | <1% | 218 | $382.63 | |
| 85027 | <1% | 1,335 | $357.73 | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 223 | $341.27 |
| 84703 | <1% | 140 | $268.55 | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 181 | $212.96 |
| 87081 | <1% | 177 | $208.97 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 85 | $173.70 |
| 82728 | <1% | 221 | $164.13 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 335 | $152.67 |
| 81025 | <1% | 46 | $148.83 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 44 | $141.28 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 563 | $131.61 |
| 80061 | Lipid panel | <1% | 1,296 | $69.24 |
| 85651 | <1% | 56 | $64.96 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,993 | $50.34 |
| 83550 | <1% | 87 | $29.98 | |
| 82607 | <1% | 102 | $26.06 | |
| 83540 | <1% | 105 | $22.20 | |
| 82077 | <1% | 14 | $20.33 | |
| 85652 | <1% | 29 | $9.26 | |
| 82570 | 0% | 27 | $0.00 | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 0% | 1,238 | $0.00 |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 0% | 112 | $0.00 |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 0% | 95 | $0.00 |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 0% | 139 | $0.00 |
| 85610 | 0% | 226 | $0.00 | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 0% | 51 | $0.00 |
| 84145 | 0% | 24 | $0.00 | |
| 87186 | 0% | 27 | $0.00 | |
| J1756 | Injection, iron sucrose, 1 mg | 0% | 30 | $0.00 |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 0% | 736 | $0.00 |
| 99213 | Doctor's office visit, returning patient (routine) | 0% | 2,234 | $0.00 |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 0% | 115 | $0.00 |
| 83735 | 0% | 56 | $0.00 | |
| 99214 | Doctor's office visit, returning patient (more involved) | 0% | 1,556 | $0.00 |
| Q3014 | Telehealth originating site facility fee | 0% | 58 | $0.00 |
| 85379 | 0% | 91 | $0.00 | |
| 77063 | Screening digital breast tomosynthesis, bilateral | 0% | 122 | $0.00 |
| J1170 | Injection, hydromorphone, up to 4 mg | 0% | 58 | $0.00 |
| 87077 | 0% | 59 | $0.00 | |
| S0020 | Injection, bupivicaine hydrochloride, 30 ml | 0% | 55 | $0.00 |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 0% | 68 | $0.00 |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 0% | 31 | $0.00 |
| A9270 | Non-covered item or service | 0% | 35 | $0.00 |
| 82746 | 0% | 30 | $0.00 | |
| 97113 | 0% | 89 | $0.00 | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 0% | 20 | $0.00 |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 19 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLANGBEHN, CODY (CEO)
| Provider | Location | Paid |
|---|---|---|
| Central Montana Medical Facilities, INC. | Lewistown, MT | $741K |
| Central Montana Medical Facilities, INC. | Lewistown, MT | $222K |
| Central Montana Medical Facilities, INC. | Lewistown, MT | $204K |
| Central Montana Medical Facilities, INC. | Lewistown, MT | $25K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.